ARTICLE | Company News
PEG-Intron/Rebetol combo approved for HCV
August 8, 2001 7:00 AM UTC
Enzon (ENZN) partner Schering-Plough (SGP) received FDA approval for PEG-Intron injection in combination with Rebetol ribavirin to treat hepatitis C virus (HCV) infection in patients with compensated ...